Uranium Participation Corporation Reports Estimated Net Asset Value, Conversion Sales and Uranium Sales at July 31, 2020
August 6, 2020
TSX Trading symbol: U
TORONTO, Aug. 6, 2020 /CNW/ - Uranium Participation Corporation ("UPC") (TSX: U) reports its estimated net asset value at July 31, 2020 was CAD$755.8 million or CAD$5.56 per share. As at July 31, 2020, UPC's uranium investment portfolio consisted of the following:
(in thousands of Canadian dollars, except quantity amounts)
Investments in Uranium:
Uranium oxide in concentrates ("U3O8")
Uranium hexafluoride ("UF6")
U3O8 fair value1 per pound:
- In Canadian dollars1
- In United States dollars
UF6 fair value1 per KgU:
- In Canadian dollars1
- In United States dollars
Fair values are month-end spot prices published by Ux Consulting Company, LLC, translated at the Bank of Canada's month-end daily exchange rate of $1.3404.
On the last trading day of July 2020, the common shares of UPC closed on the TSX at a value of CAD$4.91, which represents a 11.69% discount to the net asset value of CAD$5.56 per share.
On April 14, 2020, UPC announced that it had received approval from the TSX to acquire for cancellation, by way of a normal course issuer bid ('NCIB'), up to 12,301,750 common shares of the Corporation, during the period from April 16, 2020 to April 15, 2021. During the month of July 2020, the Corporation repurchased 680,600 shares under the NCIB.
As previously reported (in UPC's news release dated November 14, 2019), UPC has entered into commitments to sell the conversion component contained in 300,000 KgU as UF6 ("Conversion Sale") and to purchase a total of 230,000 pounds of U3O8 ("Uranium Purchase"). The Conversion Sale included the exchange of 300,000 KgU as UF6 for 783,856 pounds of U3O8 and cash consideration of USD$6,087,000 and involves three equal tranches of 100,000 KgU as UF6 for delivery in January 2020, June 2020, and July 2020. The Uranium Purchase involves the acquisition of three tranches of 100,000 pounds U3O8, 76,300 pounds U3O8, and 53,700 pounds U3O8, for delivery in October 2019, January 2020, and June 2020, respectively, at an average price of USD$26.04. In October 2019, UPC took delivery of the first tranche of 100,000 pounds U3O8. In January 2020, the first Conversion Sale was completed which resulted in an exchange of 100,000 KgU as UF6 for 261,285 pounds of U3O8, and UPC also took delivery of the Uranium Purchase's second tranche of 76,300 pounds U3O8. In June 2020, the second tranche of the Conversion Sale was completed, which resulted in an exchange of 100,000 KgU as UF6 for 261,285 pounds of U3O8, and UPC took delivery of 53,700 pounds of U3O8 from the last tranche of the Uranium Purchase. In July 2020, the final tranche of the Conversion Sale was completed, resulting in the exchange of 100,000 KgU as UF6 for 261,286 pounds of U3O8.
In addition, in the month of July, the Corporation completed two transactions to sell a total of 100,000 pounds of U3O8 at a weighted average price of US$32.63, for gross proceeds of CAD$4,425,000. The net proceeds generated by the July 2020 uranium sales were utilized to replenish the Corporation's working capital and to fund share repurchases.
About Uranium Participation Corporation
Uranium Participation Corporation is a company that invests substantially all of its assets in uranium oxide in concentrates ("U3O8") and uranium hexafluoride ("UF6") (collectively "uranium"), with the primary investment objective of achieving appreciation in the value of its uranium holdings through increases in the uranium price. UPC provides investors with a unique opportunity to gain exposure to the price of uranium without the resource or project risk associated with investing in a traditional mining company. Additional information about Uranium Participation Corporation is available on SEDAR at www.sedar.com and on UPC's website at www.uraniumparticipation.com.
Caution Regarding Forward-Looking Information
This press release contains certain forward-looking statements and forward-looking information that are based on UPC's current internal expectations, estimates, projections, assumptions and beliefs. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may", "will", "expect", "intent", "estimate", "anticipate", "plan", "should", "believe" or "continue" or the negative thereof or variations thereon or similar terminology and include statements with respect to the NCIB and UPC's plans with respect thereto; UPC's investment objectives, its uranium holdings, the transactions entered into with third parties, and agreements with respect thereto.
By their very nature, forward-looking statements involve numerous factors, assumptions and estimates. A variety of factors, many of which are beyond the control of UPC, may cause actual results to differ materially from the expectations expressed in the forward-looking statement. These factors include, but are not limited to, changes in commodity prices and foreign exchange as well as the risk that UPC will not obtain the anticipated benefits of its agreements with third parties. For a description of the principal risks of UPC, see "Risk Factors" in UPC's Annual Information Formed dated May 27, 2020 for the fiscal year ended February 29, 2020, a copy of which is available at www.sedar.com.
These and other factors should be considered carefully, and readers are cautioned not to place undue reliance on these forward-looking statements. Although management reviews the reasonableness of its assumptions and estimates, unusual and unanticipated events may occur which render them inaccurate. Under such circumstances, future performance may differ materially from those expressed or implied by the forward-looking statements. Except where required under applicable securities legislation, UPC does not undertake to update any forward-looking information statement.
SOURCE Uranium Participation CorporationDavid Cates, President & Chief Executive Officer, (416) 979-1991 Ext. 362; Mac McDonald, Chief Financial Officer, (416) 979-1991 Ext. 242